This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Fostimon

Institut Biochimique SA

Drug Names(s): urofollitropin, urinary follicle-stimulating hormone (uFSH), human FSH (hFSH)

Description: Fostimon is a pharmaceutical preparation containing human-derived FSH, i.e. the natural pituitary follicle stimulating hormone.FSH is a hormone used in selected clinical situations, to stimulate follicular development in women, or sperm formation and maturation in men.


Fostimon News

Pink Sheet Trademark Review


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug